Our Team
Established in 2021 in Vienna, Austria by visionary scientists, VERDI Solutions is at the forefront of creating personalized cancer vaccines, utilizing peptide technology and individual patients' tumor and HLA data to advance cancer treatment.
​​Dr. Julianna Lisziewicz
​​
Chief Executive Officer and Founder​
Dr. Lisziewicz founded three US companies Genetic Immunity, Inc., TREOS Bio Ltd (previously eMMUNITY Inc.) and Research Institute for Genetic and Human Therapy (RIGHT) to develop innovative vaccines that enable the human immune systems to conquer some of the deadliest diseases, including HIV and cancer.
​Dr. Franco Lori
​​
Chief Medical Officer
Dr. Lori has experience in investigative preclinical and clinical research interacting with a network of clinical, pharmaceutical, government, and basic researchers in the US and Europe. In 2000, Dr. Lori was recognized as a “Hero in Medicine” for his achievements in HIV therapy and co-authored over 100 publications.
​​Andras G. Szasz
​​
Software Architect
Mr. Szasz is a computer science engineer with experience in software development and team management. He led a team in the banking sector to automate business processes and previously identified business needs to help implement automation solutions.
​​Tamas Kos
​​
Bionics Engineer
Mr. Kos holds degrees in molecular bionics engineering and medical biotechnology, and is presently engaged in doctoral research in bioinformatics at Semmelweis University, Budapest. At VERDI Solutions, he specializes in the analysis of sequencing data. He has been involved in projects focused on extracellular vesicles and epidemic modeling.
​​Abris Heisz
​​
Software Engineer
Mr. Heisz is a computer science engineer with experience in frontend and workflow development. He led a development team and their main project was creating a task management system which focuses on managing the daily administrations of banking.